Markets:

Overview

News

Currencies

International

Treasuries

Anavex Life Sciences Corp. - Common Stock (NQ:AVXL)

3.460 +0.380 (+12.34%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 25, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Anavex Life Sciences Corp. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Alzheimer’s Treatment Market Is Anticipated To Reach $2 Billion By The End Of 2027

June 24, 2021

Via FinancialNewsMedia

Topics Death

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

June 22, 2021

Gainers Anavex Life Sciences (NASDAQ:AVXL) stock increased by 17.07% to $25.92 during Tuesday's regular session. As of 12:33 EST, this security is trading at a volume...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

June 22, 2021

Gainers vTv Therapeutics (NASDAQ:VTVT) shares rose 30.08% to $3.07 during Tuesday's pre-market session. The company's market cap stands at $251.7 million. Adial...

Via Benzinga

Why Anavex Shares Are Surging Today ↗

June 14, 2021

Anavex Life Sciences Corp (NASDAQ:AVXL) shares are tr...

Via Benzinga

The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal ↗

June 22, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 21) Agios Pharmaceuticals, Inc...

Via Benzinga

48 Biggest Movers From Yesterday ↗

June 22, 2021

Gainers Lydall, Inc. (NYSE: LDL) shares jumped 85.4% to close at $61.72 on Monday after the company agreed to be acquired by Unifrax for $61.10 per share. New Concept Energy,...

Via Benzinga

Why Anavex Life Sciences Blasted Higher Today ↗

June 21, 2021

The good news keeps coming for one of the biotech's pipeline drugs.

Via The Motley Fool

10 Health Care Stocks Showing Unusual Options Activity In Today's Session ↗

June 21, 2021

This unusual options alert can help traders track potentially big trading opportunities. Traders often look for circumstances when the market estimation of an option diverges away...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

June 21, 2021

Gainers Anavex Life Sciences (NASDAQ:AVXL) shares moved upwards by 17.07% to $25.92 during Monday's regular session. Anavex Life Sciences's stock is trading at a...

Via Benzinga

31 Stocks Moving In Monday's Mid-Day Session ↗

June 21, 2021

Gainers Lydall, Inc. (NYSE: LDL) shares climbed 82.3% to $60.68 after the company agreed to be acquired by Unifrax for $61.10 per share. Raven Industries, Inc. (NASDAQ: RAVN)...

Via Benzinga

How Anavex Extended Its 5-Week Rally On Promising Results In Rett Syndrome ↗

June 21, 2021

Anavex Life Sciences surged Monday on a positive study in Rett Syndrome, helping AVXL stock extend a triple-digit gain over a five-week rally.

Via Investor's Business Daily

Anavex Life's Rett Syndrome Candidate Shows Promising Biomarker Correlating Efficacy Data ↗

June 21, 2021

Anavex Life Sciences Corp (NASDAQ: AVXL) has reported a predictive biomarker response from its Phase 2 trial of ANAVEX2-73 (blarcamesine) in adult female patients with...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

June 21, 2021

Gainers MediciNova (NASDAQ:MNOV) shares moved upwards by 50.79% to $5.67 during Monday's pre-market session. The market value of their outstanding shares is at $276.5...

Via Benzinga

48 Biggest Movers From Yesterday ↗

June 17, 2021

Gainers Gaucho Group Holdings, Inc. (NASDAQ: VINO) shares jumped 95.1% to close at $7.98 on Wednesday. Gaucho Group highlighted the launch of its Amazon Storefront. Orphazyme A/S...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 16, 2021

Gainers Orphazyme (NASDAQ:ORPH) shares moved upwards by 72.49% to $17.34 during Wednesday's regular session. As of 12:31 EST, Orphazyme's stock is trading at a...

Via Benzinga

44 Biggest Movers From Yesterday ↗

June 16, 2021

Gainers Alzamend Neuro, Inc. (NASDAQ: ALZN) shares jumped 170% to close at $13.50 on Tuesday after the company priced its IPO at $5 per share. Alfi, Inc. (NASDAQ: ALF) shares...

Via Benzinga

Topics Initial Public Offering

Why Anavex Stock Nearly Round-Tripped Its Double-Digit Gain This Week ↗

June 15, 2021

Researchers featured a pair of Anavex Life Sciences drugs in a paper on Alzheimer's disease this week, but AVXL stock plunged on Tuesday.

Via Investor's Business Daily

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

June 15, 2021

Gainers Clearside Biomedical (NASDAQ:CLSD) stock moved upwards by 26.21% to $3.81 during Tuesday's regular session. As of 12:30 EST, this security is trading at a...

Via Benzinga

34 Stocks Moving In Tuesday's Mid-Day Session ↗

June 15, 2021

Gainers HMG/Courtland Properties, Inc. (NYSE: HMG) shares surged 133% to $27.80. Alfi, Inc. (NASDAQ: ALF) shares jumped 82.1% to $6.21 after the company inked an agreement with...

Via Benzinga

Why Anavex Life Sciences Stock Soared 35% Today ↗

June 14, 2021

Research published in a medical journal provides enormous hope for the company's pipeline Alzheimer's drug.

Via The Motley Fool

12 Health Care Stocks Moving In Monday's Intraday Session ↗

June 14, 2021

Gainers RAPT Therapeutics (NASDAQ:RAPT) shares moved upwards by 111.41% to $39.26 during Monday's regular session. As of 12:30 EST, this security is trading at a...

Via Benzinga

60 Biggest Movers From Yesterday ↗

June 15, 2021

Gainers RAPT Therapeutics, Inc. (NASDAQ: RAPT) shares jumped 115.5% to settle at $40.02 on Monday as the company announced topline results from its Phase 1b trial of RPT193 as...

Via Benzinga

40 Stocks Moving In Monday's Mid-Day Session ↗

June 14, 2021

Gainers Enochian Biosciences, Inc. (NASDAQ: ENOB) shares jumped 127.2% to $10.02. The FDA has accepted Enochian BioSciences Inc's pre-IND (Investigational New Drug) request...

Via Benzinga

Anavex Life Sciences' Alzheimer's Candidate Mechanism Of Action Explained In Medical Journal ↗

June 14, 2021

Anavex Life Sciences Corp (NASDAQ: AVXL) has reported that ANAVEX 2-73 (blarcamesine) and ANAVEX3-71 (AF710B) are featured in a new peer-reviewed publication in...

Via Benzinga

Biotechs Ready To Roar ↗

June 13, 2021

The biggest event last week was the FDA decision to approve Biogen's drug aducanumab, a treatment for Alzheimer's disease. The decision will reverberate across the industry and the healthcare sector...

Via Talk Markets

Biogen Snagged: Will Hefty Price Tag Hinder Alzheimer's Drug Use? ↗

June 08, 2021

Biogen stock dipped Tuesday as analysts questioned how much use its potential blockbuster Alzheimer's treatment, Aduhelm, would ultimately secure.

Via Investor's Business Daily

Biogen Wins Landmark Alzheimer's Approval: 5 Things To Know About Aducanumab ↗

June 07, 2021

The FDA approved Biogen's Alzheimer's treatment, aducanumab, on Monday — though Biogen stock remained halted into the long-awaited decision.

Via Investor's Business Daily

The Fight Against Alzheimer's Reaches A Moment Of Truth For Biogen, Other Biotech Stocks ↗

May 21, 2021

The FDA will soon review aducanumab, possibly the first new Alzheimer's treatment in years. Stakes are high for Biogen stock — and other biotech stocks too.

Via Investor's Business Daily

Anavex Life Sciences (AVXL) Q2 2021 Earnings Call Transcript ↗

May 14, 2021

AVXL earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use ↗

May 13, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 12) Alexion Pharmaceuticals, Inc...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Anavex Life Sciences Corp. - Common Stock (NQ:AVXL)

All News about Anavex Life Sciences Corp. - Common Stock

Starting at $3.75/week.

Subscribe Today